Here, we identify low-density lipoprotein receptor class A domain-containing 2 (LDLRAD2) as a driver of extramedullary infiltration (EMI) through analyses of patient samples, public datasets, AML cell models, and xenografts. The gene discussed is LDLRAD2; the disease is acute myeloid leukemia.